Fasting can improve blood sugar control in people with type 2 diabetes, but it comes with real risks depending on what medications you take. In one 16-week clinical trial published in JAMA Network Open, participants following a 5:2 intermittent fasting plan (eating normally five days a week and restricting calories on two) reduced their HbA1c by 1.9 percentage points, slightly outperforming two common diabetes medications tested in the same study. That’s a meaningful improvement. But the picture is more nuanced than the headline suggests.
What the Evidence Shows for Type 2 Diabetes
The strongest clinical data comes from structured fasting plans combined with meal replacements. In the JAMA Network Open trial, the 5:2 fasting group’s 1.9% HbA1c reduction over 16 weeks compared favorably to metformin (1.6% reduction) and empagliflozin (1.5% reduction). Those are significant numbers: every percentage point drop in HbA1c translates to lower risk of diabetes complications like nerve damage, kidney disease, and vision problems.
A longer, 12-month study found more modest results. When 5:2 intermittent fasting was compared to simply cutting daily calories, the fasting group achieved about a 0.5% greater reduction in HbA1c. That suggests the short-term benefits may partially level off over time, or that the difference between fasting and standard calorie restriction narrows as both groups adjust.
When it comes to weight loss, the comparison with traditional dieting is interesting. A review of human studies found that daily calorie restriction actually produces greater total weight loss than intermittent fasting. However, both approaches reduce visceral fat (the deep abdominal fat most closely linked to insulin resistance) by comparable amounts. They also produce similar improvements in fasting insulin levels and insulin resistance. So if your main goal is improving how your body handles insulin, fasting doesn’t appear to have a unique metabolic advantage over simply eating less every day.
Why Medication Type Matters
The biggest safety concern with fasting and diabetes is hypoglycemia, when blood sugar drops dangerously low. Your risk depends heavily on what you’re taking to manage your diabetes.
If you use insulin, you’re at the highest risk. Insulin directly forces glucose out of your bloodstream, and when you’re not eating, that effect can cause a steep, fast drop in blood sugar. In studies of fasting diabetic patients, people on insulin consistently experienced more hypoglycemic episodes than those on oral medications, and many required dose reductions to fast safely.
Among oral medications, sulfonylureas (a class of drugs that stimulate your pancreas to release insulin regardless of whether you’ve eaten) carry notably higher risk. During Ramadan fasting studies, 17.8% of patients on sulfonylureas experienced hypoglycemia, compared to 8.6% on newer medications like liraglutide. Symptomatic episodes with dizziness or sweating were even more lopsided: 11% in the sulfonylurea group versus just 2% with liraglutide.
Metformin, by contrast, works differently. It reduces how much glucose your liver produces rather than forcing insulin release, so it carries a much lower hypoglycemia risk during fasting. In clinical protocols for Ramadan fasting, metformin doses were often kept the same while insulin doses were cut by 25% or more and sulfonylurea doses were reduced to 75% of normal.
The 16:8 Approach and Daily Blood Sugar
Time-restricted eating, where you compress all meals into an 8-hour window and fast for 16 hours, is the most popular fasting format. But the evidence for blood sugar benefits is surprisingly thin. A study using continuous glucose monitors found that restricting the eating window from about 11 hours to 7 hours produced no changes in average daily glucose, no improvements in glucose variability (the spikes and crashes throughout the day), and no change in time spent above or below the normal blood sugar range of 70 to 180 mg/dL.
That study was in people without diabetes, so the results may differ for those with impaired blood sugar regulation. But it challenges the assumption that simply changing when you eat, without changing how much you eat, automatically improves glucose control. The calorie deficit likely matters more than the fasting window itself.
Type 1 Diabetes Is a Different Situation
If you have type 1 diabetes, fasting carries distinct risks because your body produces no insulin on its own. In a controlled trial testing 36-hour fasts in adults with type 1 diabetes, hypoglycemic episodes occurred in both short and prolonged fasting periods, with blood sugar dropping to around 64 mg/dL during these events. The study found that the type of insulin delivery also mattered: during shorter 12-hour fasts, people using multiple daily injections spent significantly more time in the target glucose range (83%) compared to those using insulin pumps (62%), though this difference disappeared during longer fasts.
Fasting with type 1 diabetes requires careful, individualized insulin adjustments and close monitoring. The margin for error is much smaller than with type 2, and the potential consequences of getting it wrong, including diabetic ketoacidosis, are more severe.
What Makes Fasting Work (and What Doesn’t)
At the cellular level, fasting triggers some measurable changes in muscle tissue. After two weeks of intermittent fasting, researchers found increased activity in a pathway involved in glycogen storage (how your muscles store glucose for energy) and decreased activity in a growth-signaling pathway called mTOR. But these molecular shifts didn’t translate into measurable improvements in whole-body glucose metabolism, lipid processing, or protein metabolism in healthy lean men. The cellular changes were real; the practical impact on blood sugar was not detectable.
This matters because it suggests fasting’s benefits for diabetes aren’t driven by some unique metabolic switch that flips during food restriction. The benefits more likely come from the calorie deficit fasting creates, the resulting fat loss (particularly visceral fat), and the downstream improvement in insulin sensitivity that follows. If you find fasting easier to stick with than counting calories every day, that’s a legitimate reason to prefer it. But it’s the energy deficit doing the heavy lifting, not the fasting itself.
Practical Risks to Plan For
If you’re considering fasting with diabetes, the risks cluster around a few specific scenarios:
- Low blood sugar episodes: Most likely if you take insulin or sulfonylureas. Symptoms include dizziness, sweating, confusion, and shakiness. These medications may need dose reductions of 25% or more during fasting days.
- Rebound overeating: Some people compensate for fasting days by eating significantly more on non-fasting days, which can worsen blood sugar spikes and negate the calorie deficit.
- Dehydration: Fasting protocols that also restrict fluids (as in some religious fasts) compound the risk, since high blood sugar already increases fluid loss through urination.
The American Diabetes Association’s 2024 Standards of Care added a specific subsection on religious fasting, recognizing that millions of people with diabetes fast for spiritual reasons each year. The guidelines also introduced the concept of chrononutrition, acknowledging that meal timing can influence how your body processes food through its effects on circadian rhythms. This represents a shift toward treating fasting as a real dietary pattern that warrants clinical guidance rather than something to simply discourage.
Fasting can be a useful tool for managing type 2 diabetes, particularly for people who find it easier than daily calorie counting. But it’s not a metabolic shortcut, and for anyone on insulin or certain oral medications, it requires careful planning and medication adjustments to avoid dangerous blood sugar drops.